Phathom Pharmaceuticals Files 8-K
Ticker: PHAT · Form: 8-K · Filed: Mar 7, 2024 · CIK: 1783183
| Field | Detail |
|---|---|
| Company | Phathom Pharmaceuticals, Inc. (PHAT) |
| Form Type | 8-K |
| Filed Date | Mar 7, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials
TL;DR
Phathom Pharma dropped an 8-K, check it for financial updates.
AI Summary
Phathom Pharmaceuticals, Inc. filed an 8-K on March 7, 2024, to report on its results of operations and financial condition, as well as to file financial statements and exhibits. The filing does not contain specific financial figures or operational details within the provided text.
Why It Matters
This filing indicates that Phathom Pharmaceuticals is providing updates on its financial status and operational results to the SEC. Investors should review the full filing for detailed financial information.
Risk Assessment
Risk Level: low — The filing is a standard corporate disclosure and does not inherently present new risks.
Key Players & Entities
- Phathom Pharmaceuticals, Inc. (company) — Registrant
- March 7, 2024 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Florham Park, New Jersey (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing by Phathom Pharmaceuticals?
The primary purpose is to report on the company's results of operations and financial condition, and to file financial statements and exhibits.
On what date was this 8-K report filed?
The report was filed on March 7, 2024.
In which state is Phathom Pharmaceuticals incorporated?
Phathom Pharmaceuticals, Inc. is incorporated in Delaware.
What is the address of Phathom Pharmaceuticals' principal executive offices?
The principal executive offices are located at 100 Campus Drive, Suite 102, Florham Park, New Jersey 07932.
What is the registrant's telephone number?
The registrant's telephone number is (877) 742-8466.
Filing Stats: 527 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-03-07 08:06:53
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share PHAT The Nasdaq Global Se
Filing Documents
- d759734d8k.htm (8-K) — 23KB
- d759734dex991.htm (EX-99.1) — 84KB
- 0001193125-24-061512.txt ( ) — 243KB
- phat-20240307.xsd (EX-101.SCH) — 3KB
- phat-20240307_lab.xml (EX-101.LAB) — 18KB
- phat-20240307_pre.xml (EX-101.PRE) — 11KB
- d759734d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PHATHOM PHARMACEUTICALS, INC. Date: March 7, 2024 By: /s/ Larry Miller Larry Miller General Counsel and Secretary